J0577 Medicaid Rate by State

Injection, buprenorphine extended-release (brixadi), less than or equal to 7 days of therapy

29 state Medicaid programs publish a fee-for-service rate for J0577 (injection, buprenorphine extended-release (brixadi), less than or equal to 7 days of therapy), ranging from $362.93 in Idaho to $466.20 in Indiana among rates on the same basis.

Every state, kept current

Every code in every state: the Rates plan

$29 /mo, 7-day free trial

  • Every code on all 51 published schedules
  • Full-schedule CSV export and state network lists
  • Email alerts when a state changes its rates
Start free trial$29/mo after the trial; a trial exports 50-row samples

Or one file, no account: Drugs across 33 states, 1,225 codes.

2026-11-19 edition, standardized by ProviderSignal. Secure checkout by Stripe; download link by email, 5 downloads in 30 days. License · Every file we sell

Publishing states

29

Median % of Medicare

--

Rate range, like rates

$362.93 - $466.20

J0577 rates in every publishing state

  • Alabama$420.64

    2026

  • Arkansas$404.09

    2026

  • Arizona$407.23

    surgery center payment

    2026

  • California$421.67

    2026

  • Connecticut$420.05

    2026

  • District of Columbia$420.05

    Prior auth: not required, 2026

  • Idaho$362.93

    Prior auth: not required, 2026

  • Illinois$405.95

    2026

  • Indiana$466.20

    Prior auth: required, 2026

  • Kansas$430.58

    2026

  • Kentucky$420.05

    surgery center payment

    2026

  • Maryland$420.05

    2026

  • Michigan$430.58

    2026

  • Minnesota$430.57

    Prior auth: required, 2026

  • Mississippi$417.21

    2026

  • Montana$420.05

    variant HG

    Prior auth: required, 2026

  • Nebraska$430.57

    2026

  • New Hampshire$444.00

    Prior auth: not required, 2026

  • New Jersey$422.73

    Prior auth: not required, 2026

  • New Mexico$428.66

    2025

  • Oklahoma$433.17

    2026

  • Rhode Island$445.85

    hospital outpatient payment

    2026

  • South Carolina$433.17

    2026

  • Texas$422.83

    2026

  • Utah$430.58

    Prior auth: not required, 2026

  • Virginia$430.57

    ages 18 and up

    2026

  • Vermont$399.61

    2026

  • Washington$430.58

    2026

  • Wisconsin$430.58

    2026

Published Medicaid fee-for-service schedule amounts, not a coverage or eligibility guarantee. Managed-care plan rates can differ. Where no prior-authorization flag is shown, the state does not publish one. A state that lists the code more than one way shows one of its rows here, with its basis: a rental is not a purchase price. "--" in the prior-auth column means the state publishes no PA flag.

Related drugs codes

All 224 codes from J0013 to J0911 or every drugs code by number.

Frequently asked questions

How much does Medicaid pay for J0577?

29 state Medicaid programs publish a fee-for-service rate for J0577 (injection, buprenorphine extended-release (brixadi), less than or equal to 7 days of therapy), ranging from $362.93 in Idaho to $466.20 in Indiana among rates on the same basis. The full table on this page lists every publishing state's current rate.

Which state pays the most for J0577?

Indiana publishes the highest Medicaid rate for J0577 at $466.20. Idaho publishes the lowest at $362.93, among rates on the same basis; rentals and rates far from the other states' are in the table with their basis.

Does J0577 require prior authorization under Medicaid?

3 of the 29 publishing states flag J0577 as requiring prior authorization (always or conditionally) on their fee schedules. States without a flag publish no PA indicator for this code - that means "not published", not "no PA required".